Publication: 2710

High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)
      QxMD      Google Scholar   
Citation:
Blood Cancer J vol 7 (6) e576-
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Long-Term-Followup
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
6
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, CA025224, U10CA180790, U10 CA180821, U10 CA180882  
Corr. Author:
 
Authors:
                     
Networks:
LAPS-MN026   
Study
NCCTG-N1085
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
1
Keywords:
Letter to the Editor